S100 Proteins as Biomarkers in Risk Estimations for Malignant Transformation in Oral Lesions
Oncologic relevant members of S100 proteins are described as promising biomarkers in molecular pathology for risk estimation in oral neoplasia exhibiting different stages of malignancy: gingiva as healthy tissue, irritation fibroma as benign, leukoplakia as precancerous, and oral squamous cell carcinoma as malignant entity. Gene expression levels of S100A4 (metastasin), S100A7 (psoriasin), S100A8 (calgranulin A), and S100A9 (calgranulin B) were analyzed using quantitative RT-PCR. In addition, immunohistochemistry-based microscopy was used to examine cellular localization and distribution of these biomarkers in tissue sections. The results indicate that S100 proteins represent promising biomarkers for early-stage diagnosis in oral lesions. The inclusion of expression profiles and ratios for each entity even improves their diagnostic validity.
Key wordsS100 proteins Calcium binding EF-hand Molecular pathology Biomarkers Oral lesions Early-stage diagnosis
R. Probstmeier and D. Kraus contributed equally to this work.
- 6.Wenghoefer M, Pantelis A, Najafi T, Deschner J, Allam JP, Novak N, Reich R, Martini M, Bergé S, Fischer HP, Jepsen S, Winter J (2010) Gene expression of oncogenes, antimicrobial peptides, and cytokines in the development of oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110:351–356CrossRefGoogle Scholar
- 7.Winter J, Pantelis A, Allam JP, Novak N, Reich R, Martini M, Bergé S, Deschner J, Jepsen S, Wenghoefer M (2011) High α-defensin and S100A7 expression and missing DOC-1 down-regulation characterize irritation fibromas of the oral cavity and might counteract malignant transformation. J Craniofac Surg 22:100–104CrossRefGoogle Scholar
- 9.Reckenbeil J, Kraus D, Probstmeier R, Allam JP, Novak N, Frentzen M, Martini M, Wenghoefer M, Winter J (2016) Cellular distribution and gene expression pattern of metastasin (S100A4), Calgranulin A (S100A8), and Calgranulin B (S100A9) in oral lesions as markers for molecular pathology. Cancer Investig 34:246–254CrossRefGoogle Scholar
- 10.Harris TM, Du P, Kawachi N, Belbin TJ, Wang Y, Schlecht NF, Ow TJ, Keller CE, Childs GJ, Smith RV, Angeletti RH, Prystowsky MB, Lim J (2015) Proteomic analysis of oral cavity squamous cell carcinoma specimens identifies patient outcome—associated proteins. Arch Pathol Lab Med 139:494–507CrossRefGoogle Scholar